Saiko-ka-ryukotsu-borei-to, a herbal medicine, ameliorates chronic stress-induced depressive state in rotarod performance

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 2, 2003, Pages 419-425

  Mizoguchi, Kazushige ^a   Yuzurihara, Mitsutoshi ^a   Ishige, Atsushi ^a   Aburada, Masaki ^a   Tabira, Takeshi ^b  

^a TSUMURA AND CO   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Chronic stress; Depression; Dopamine; Herbal medicine; Prefrontal cortex; Rat; Rotarod performance; Saiko ka ryukotsu borei to; Serotonin

Indexed keywords

DOPAMINE; HERBACEOUS AGENT; SAIKO KA RYUKOTSU BOREI TO; SAIKO-KA-RYUKOTSU-BOREI-TO; SEROTONIN;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; CHRONIC DISEASE; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EVALUATION; EXTRACELLULAR SPACE; HAND GRIP; HERBAL MEDICINE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; MENTAL STRESS; METABOLISM; MICRODIALYSIS; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; PHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RAT; RAT STRAIN; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM; STRESS; TASK PERFORMANCE; WATER IMMERSION;

EID: 0038784584     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00131-X     Document Type: Article

References (43)

1. Ahmad B., Nicholls P.J. Development of tolerance to the CNS effects of aminoglutethimide in mice. Eur. J. Pharmacol. 182:1990;237-244.
2. Anisman M.E., Farabollini F. Depression; the predisposing influence of stress. Behav. Brain Sci. 5:1982;89-137.
3. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch. Gen. Psychiatry. 42:1985;1193-1204.
4. Calabrese J.R., Markovitz P.J. Treatment of depression. New pharmacologic approaches. Prim. Care. 18:1991;421-433.
5. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F.et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Arch. Gen. Psychiatry. 38:1981;15-22.
6. Commissaris R.L., Rech R.H. Tolerance and cross-tolerance to central nervous system depressants after chronic pentobarbital or chronic methaqualone administration. Pharmacol. Biochem. Behav. 18:1983;327-331.
7. Cummings J.L. Depression and Parkinson's disease: a review. Am. J. Psychiatry. 149:1992;443-454.
8. Deutch A.Y. Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J. Neural Transm. 91:1993;197-221.
9. Dolan R.J., Bench C.J., Brown R.G., Scott L.C., Frackowiak R.S. Neuropsychological dysfunction in depression: the relationship to regional cerebral blood flow. Psychol. Med. 24:1994;849-857.
10. Drevets W.C., Price J.L., Simpson J.R. Jr., Todd R.D., Reich T., Vannier M.et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
11. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Greer P.J., Mathis C. Serotonin type-1A receptor imaging in depression. Nucl. Med. Biol. 27:2000;499-507.
12. Dunhan N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
13. Fibiger H.C. Neurobiology of depression: focus on dopamine. Adv. Biochem. Psychopharmacol. 49:1995;1-17.
14. Haracz J.L., Minor T.R., Wilkins J.N., Zimmermann E.G. Learned helplessness: an experimental model of the DST in rats. Biol. Psychiatry. 23:1988;388-396.
15. Hiai S., Sasaki S., Oura H. Effect of ginseng saponin on rat adrenal cyclic AMP. Planta Med. 37:1979;15-19.
16. Hiai S., Yokoyama H., Nagasawa T., Oura H. Stimulation of the pituitary-adrenocortical axis by saikosaponin of Bupleuri radix. Chem. Pharm. Bull. 29:1981;495-499.
17. Holsboer F. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects. J. Steroid Biochem. 19:1983;251-257.
18. Iizuka S., Ishige A., Komatsu Y., Matsumiya T., Tsuji M., Takeda H. Effects of saiko-ka-ryukotsu-borei-to on irritable characteristics in El mice. Methods Find. Exp. Clin. Pharmacol. 20:1998;19-26.
19. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structure: role of corticosterone. Eur. J. Pharmacol. 165:1989;337-339.
20. Kalin N.H., Weiler S.J., Shelton S.E. Plasma ACTH and cortisol concentration before and after dexamethasone. Psychiatry Res. 7:1982;87-92.
21. Koshikawa N., Imai T., Takahashi I., Yamauchi M., Sawada S., Kansaku A. Effects of hochu-ekki-to, yoku-kan-san and saiko-ka-ryukotsu-borei-to on behavioral despair and acetic acid-induced writhing in mice. Methods Find. Exp. Clin. Pharmacol. 20:1998;47-51.
22. Kuribara H., Higuchi Y., Tadokoro S. Effects of central depressants on rota-rod and traction performance in mice. Jpn. J. Pharmacol. 27:1977;117-126.
23. Kuroda Y., Mikuni M., Ogawa T., Takahashi K. Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding site in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology. 108:1992;27-32.
24. Kuroda Y., Mikuni M., Nomura N., Takahashi K. Differential effect of subchronic dexamethasone treatment on serotonin-2 and β-adrenergic receptors in the rat cerebral cortex and hippocampus. Neurosci. Lett. 155:1993;195-198.
25. Lane R., Baldwin D., Preskorn S. The SSRIs: advantages and differences. J. Psychopharmacol. 92:1995;163-178. [Suppl.].
26. Lee Y.J., Chung E., Lee K.Y., Lee Y.H., Huh B., Lee S.K. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol. Cell. Endocrinol. 133:1997;135-140.
27. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology. 55:1992;444-450.
28. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. J. Neurosci. 20:2000;1568-1574.
29. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Chui D.H., Tabira T. Chronic stress differentially regulates glucocorticoid negative feedback response in rats. Psychoneuroendocrinology. 26:2001;443-459.
30. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Tabira T. Chronic stress impairs rotarod performance in rats: implications for depressive state. Pharmacol. Biochem. Behav. 71:2002;79-84.
31. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Tabira T. Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment. Pharmacol. Biochem. Behav. 72:2002;723-728.
32. Mizoguchi K., Yuzurihara M., Ishige A., Sasaki H., Tabira T. Saiko-ka-ryukotsu-borei-to, an herbal medicine, prevents chronic stress-induced disruption of glucocorticoid negative feedback in rats. Life Sci. 72:2002;67-77.
33. Morimoto S., Kito G. Rotarod method in young rats and the antidepressive effect: is the rotarod method capable of evaluating antidepressive effects? Folia Pharmacol. Jpn. 104:1994;39-49.
34. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40:1994;288-295.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, New York.
36. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 266:1977;730-732.
37. Sasaki K., Suzuki K., Yoshizaki F., Ando T. Effect of saiko-ka-ryukotsu-borei-to on the stress-induced increase of serum corticosterone in mice. Biol. Pharm. Bull. 18:1995;563-565.
38. Sasaki K., Suzuki K., Ueno M., Takako K., Yoshizaki F. Increase in monoamine levels caused by emotional stress in mice brain regions is attenuated by saiko-ka-ryukotsu-borei-to. Methods Find. Exp. Clin. Pharmacol. 20:1998;27-30.
39. Slotkin T.A., McCook E.C., Ritchie J.C., Seidler F.J. Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol. Psychiatry. 40:1996;576-584.
40. Steckler T., Holsboer F., Reul J.M. Glucocorticoids and depression. Baillière's Best Pract. Res. Clin. Endocrinol. Metab. 13:1999;597-614.
41. Yamada K., Kanba S. Kampo therapy and stress in the field of neuropsychiatry. Prog. Med. 17:1997;817-822.
42. Yokoyama H., Hiai S., Oura H. Chemical structures and corticosterone secretion-inducing activities of saikosaponins. Chem. Pharm. Bull. 29:1981;500-504.
43. Young E.A., Akana S., Dallman M.F. Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats. Neuroendocrinology. 51:1990;536-542.